Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial

Posted on by

Lancet Infectious Diseases
Apr 2019  Volume 19Number 4p339-448, e109-e147
http://www.thelancet.com/journals/laninf/issue/current

Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial
Yan Li, et al.